Fig. 7
From: Rapid preparation of bioactive composites for transforaminal lumbar interbody fusion
A typical case of a patient (Female, 56 years old, diagnosed with lumbar disc herniation and lumbar spinal stenosis) who received SECCS treatment at the L4/5 level. (A) The sagittal MRI of lumber spine before surgery. (B) The transverse MRI of L4/5 before surgery. (C) Cage filled with bioactive MSC/β-TCP. (D) Postoperative cross-sectional CT showed that the fusion cage was placed transversely in the L4/5 intervertebral space. (E-G) Three-, six-, and twelve-month follow-up of the L4/5 intervertebral fusion by sagittal CT scan.
